rs1635501 — EXO1 EXO1 rs1635501

Intronic variant in EXO1 (exonuclease 1), a DNA mismatch repair and meiotic recombination enzyme; each copy of the C allele is associated with approximately 10 fewer weeks before natural menopause onset, implicating impaired oocyte DNA repair in accelerated follicle depletion

See your personal result for EXO1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

EXO1 rs1635501 — A DNA Repair Variant Linked to Ovarian Aging

The timing of natural menopause is one of the most heritable aspects of female reproductive biology, with an estimated heritability of 50–60%. Genome-wide association studies have repeatedly converged on the same biological theme: DNA repair genes dominate the genetic landscape of ovarian aging. Among these, EXO1 (exonuclease 1)11 EXO1 (exonuclease 1)
a 5′→3′ exonuclease critical for DNA mismatch repair and meiotic recombination stands out for having both a GWAS-level population signal and a well-characterised functional mechanism. The intronic variant rs1635501 at the EXO1 locus tags a nearby functional promoter change, and each copy of the C allele may shift menopause onset approximately 10 weeks earlier.

The Mechanism

EXO1 encodes a multifunctional nuclease with two essential roles in genome maintenance. In DNA mismatch repair (MMR)22 DNA mismatch repair (MMR)
a post-replication proofreading system that corrects base-base mismatches and small insertion/deletion loops introduced during DNA replication, EXO1 is recruited downstream of MutSα/MutLα recognition to excise the mismatch-containing strand, creating a gap that is filled accurately by DNA polymerase. In meiosis, EXO1 is recruited by the MRN complex to double-strand break sites where it resects DNA ends, generating 3′ single-stranded overhangs that are essential for homologous recombination and crossover formation — the chiasmata that physically hold homologous chromosomes together until anaphase I.

The reproductive consequence of EXO1 loss is severe. EXO1 knockout mice are completely infertile in both sexes33 EXO1 knockout mice are completely infertile in both sexes
Wei et al. 2003, Genes Dev 17:603–614. Exo1−/− oocytes progress normally through prophase I but lose chiasmata at metaphase I, triggering apoptosis. The ovaries of knockout females are smaller than wild-type and show progressive oocyte loss. This dramatic phenotype established that EXO1 activity is not merely beneficial but essential for oocyte viability during meiosis.

The rs1635501 variant is intronic and does not alter the EXO1 protein sequence. Its effect is mediated through a nearby functional polymorphism (rs1776180) in the EXO1 promoter (r² = 0.83 in European panels). The rs1776180 C allele disrupts a binding site for E47, a basic helix-loop-helix transcription factor that acts as a negative regulator of EXO1 transcription44 E47, a basic helix-loop-helix transcription factor that acts as a negative regulator of EXO1 transcription
Lunetta et al. 2009, Mech Ageing Dev 130:438–445. Loss of E47 repression leads to higher EXO1 expression. Paradoxically, this higher-expression allele associates with earlier menopause in the population GWAS yet with greater longevity in centenarian studies — likely because the population menopause signal captures the cumulative cost of elevated EXO1 activity on oocyte DNA processing across decades of meiotic arrest.

The Evidence

The primary evidence comes from the Stolk et al. 2012 meta-analysis of 22 genome-wide association studies55 Stolk et al. 2012 meta-analysis of 22 genome-wide association studies
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nature Genetics 44:260–268, which examined 38,968 women of European descent with replication in 14,435 additional women. At the EXO1 locus (region 1b), rs1635501 reached P = 8.46×10⁻¹⁰ with a beta of −0.188 years (approximately −9.8 weeks) per C allele in the additive model. Among the 13 novel loci identified, EXO1 was one of eight that harbour DNA damage response genes — a striking enrichment that the authors highlighted as evidence for a shared biological mechanism linking DNA repair capacity to ovarian reserve maintenance.

A substantially larger analysis by Ruth et al. 202166 Ruth et al. 2021
Genetic insights into biological mechanisms governing human ovarian ageing. Nature 596:393–397 expanded the GWAS to approximately 200,000 European women and identified 290 loci associated with age at natural menopause, confirming EXO1 and broadly validating the DNA repair pathway enrichment first observed in the Stolk analysis. That study also demonstrated that women in the top 1% of genetic susceptibility — as defined by polygenic scores across all identified loci — carry a risk of premature ovarian insufficiency (POI) comparable to carriers of FMR1 premutations, the best-known monogenic cause of POI.

The mechanistic case is reinforced by a centenarian study by Lunetta et al. 200977 centenarian study by Lunetta et al. 2009
A functional EXO1 promoter variant is associated with prolonged life expectancy in centenarians. Mech Ageing Dev 130:438–445 showing that the promoter variant in LD with rs1635501 is enriched in long-lived women — pointing to EXO1 expression as a pleiotropic regulator of both meiotic competence and somatic DNA maintenance across the lifespan.

EXO1 coding variants have also been explored in women with premature ovarian failure. A variant analysis in 186 Chinese POF patients by Zhu et al. 201688 variant analysis in 186 Chinese POF patients by Zhu et al. 2016
Variation analysis of EXO1 gene in Chinese patients with premature ovarian failure. J Ovarian Res 2016 found no causal coding mutations, suggesting the GWAS signal at rs1635501 acts through the non-coding regulatory mechanism rather than protein-level dysfunction.

Practical Actions

The rs1635501 locus contributes a modest but real additive effect on reproductive lifespan. For women carrying one or two C alleles, the primary clinical implication is earlier consideration of ovarian reserve assessment — particularly for those with other risk factors (family history of early menopause, autoimmune conditions, prior chemotherapy or pelvic radiotherapy). The ~10-week shift per allele is a population average, and serum AMH with antral follicle count provides a direct and individually calibrated measure of current reserve that no polygenic estimate can replace.

Because the biological mechanism involves DNA repair in oocytes, and because EXO1-deficient oocytes are specifically vulnerable to oxidative DNA damage that accumulates across the decades of meiotic arrest, minimising exogenous genotoxic exposures is a plausible and evidence-consistent risk-reduction strategy — particularly tobacco smoke, which delivers polycyclic aromatic hydrocarbons and other oocyte-toxic genotoxins directly to the follicular microenvironment.

Interactions

The ovarian aging signal from DNA repair loci is collectively enriched beyond what individual loci predict, suggesting additive convergence through shared pathways. The most clinically relevant co-variant is rs10183486 (TLK1), another DNA repair gene locus associated with approximately 10 weeks earlier menopause per allele in the same Stolk 2012 analysis. Women carrying C alleles at rs1635501 and T alleles at rs10183486 may have additive reduction in reproductive lifespan, though a formal published compound analysis of this pair has not been reported. The HELQ locus (rs4693089) and the POLG/FANCI locus (rs2307449) identified in the same study operate in overlapping double-strand break repair and mitochondrial replication pathways respectively, and are noted in related_snps for cross-reference.

Genotype Interpretations

What each possible genotype means for this variant.

TT Normal

No elevated ovarian aging signal at this EXO1 locus

The TT genotype at rs1635501 is the reference state at this locus. It does not carry the promoter-disrupting allele (rs1776180 C) that alters E47 binding and modulates EXO1 expression; EXO1 transcription in oocytes is expected to be unperturbed by this variant in TT individuals.

This does not mean ovarian reserve is guaranteed to be normal — AMH and antral follicle counts are influenced by more than 290 genetic loci as well as environmental exposures, prior medical history, and lifestyle factors. The TT genotype at rs1635501 simply removes one known genetic contributor to earlier reserve decline from consideration.

CT One C allele — moderate ovarian aging signal Intermediate

One copy of the earlier-menopause allele — modestly earlier natural menopause may be expected at the population level

The C allele at rs1635501 acts additively — CT heterozygotes are intermediate between CC homozygotes (highest risk) and TT homozygotes (reference) for menopause timing. The ~10-week earlier onset per allele is a population-average estimate from a large European GWAS. At the individual level, a CT carrier may have slightly lower AMH on average for their age than TT individuals, but the distributions overlap substantially and individual AMH measurement is the only way to assess reserve directly.

The rs1635501 C allele tags a functional EXO1 promoter variant that modulates EXO1 expression in oocytes. EXO1 is essential for meiotic recombination and double-strand break repair; its activity in oocytes appears to influence the rate at which follicles are lost to DNA-damage-induced apoptosis during the decades of meiotic arrest. CT heterozygotes carry one copy of the expression-altering allele, representing an intermediate expression state.

CC Two C alleles — stronger ovarian aging signal High Risk

Two copies of the earlier-menopause allele — may be associated with a shortened reproductive lifespan

CC homozygosity at rs1635501 places you at the high-risk end of the EXO1 locus distribution for reproductive aging. The variant is intronic and tags (r²=0.83) a functional promoter polymorphism (rs1776180) that disrupts a binding site for the E47 transcription factor — a negative regulator of EXO1. The result is altered EXO1 expression in oocytes, where this enzyme is essential for meiotic recombination and double-strand break repair during the decades of prophase I arrest.

Mouse genetic data are instructive: complete EXO1 deficiency causes total female infertility through meiotic failure, establishing that adequate EXO1 function is critical for oocyte survival. The population GWAS signal suggests that even the modest expression changes tagged by rs1635501 contribute to a quantitative shift in ovarian reserve maintenance across time.

Important context: (1) The ~20-week estimate is a population average from European women; it is not a prediction for any individual. (2) EXO1 is one of at least 290 loci influencing menopause timing — a single locus explains only a fraction of total variance. (3) Serum AMH and antral follicle count are the clinically established tools for quantifying your actual reserve; genotype provides directional context, not a precise forecast. (4) No ClinVar pathogenicity classification exists for rs1635501.